Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I  IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Fortrea Holdings Inc.

In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on Fortrea Holdings Inc., with a price target of $12.00....

Truist Financial Keeps Their Hold Rating on Fortrea Holdings Inc. (FTRE)

Fortrea Holdings Inc. (($FTRE)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Fortrea Ho...

Fortrea Holdings Inc. Navigates Growth and Challenges in Q3 Earnings Call

Fortrea Holdings Inc. (($FTRE)) announced an update on their ongoing clinical study. Fortrea Holdings Inc. is collaborating with Italfarmaco on a P...

Current Yield	N/A	Payout Ratio	N/A
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FTRE	$10.90	+8.57%	942.82K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FTRE	$10.90	+8.6%	942.82K
3
4
5
6

FTRE

FTRE

Dividend Overview

Get Fortrea Holdings Inc. Data in Excel

Get Fortrea Holdings Inc. Data in Excel